Nova Leap Health Corp. Grants Stock Options

Nova Leap Health Corp., a prominent home health care organization based in Halifax, Nova Scotia, announced on December 12, 2025, the issuance of stock options as part of its employee incentive strategy. The company granted a total of 950,000 stock options to its directors, officers, and senior employees. These options come with an exercise price of CAD $0.35 per share and have a validity period of 10 years. The vesting schedule for the options is set to allow for 25% to vest immediately, with an additional 25% vesting on each anniversary of the grant date.

This move aligns with the company’s strategy under its Third Amended and Restated Equity Incentive Plan, aiming to attract and retain talent amidst the growing demand for home health care services. Nova Leap is recognized for its strong position in the rapidly expanding home health care sector in both the U.S. and Canada, addressing critical needs for individuals, especially those requiring specialized care such as dementia support.

The company has demonstrated impressive growth, being ranked #42 in the 2021 Report on Business Top Growing Companies in Canada and securing high rankings in previous years as well. Nova Leap's operations span various regions, including New England, Southeastern, South Central, and Midwest areas in the United States, along with services in Nova Scotia.

Investors and stakeholders are encouraged to note that this press release is intended solely for informational purposes and is not for dissemination within the United States or to U.S. newswire services. For more details, Chris Dobbin, the company’s President and CEO, is available for inquiries.

Nova Leap Health Corp. (TSXV: NLH) recently announced the issuance of 950,000 stock options to its directors, officers, and senior employees at an exercise price of CAD$0.35 per share, which can be seen as a strategic move to align the interests of management with shareholders. This decision illustrates the company's confidence in its future growth prospects, particularly within the rapidly expanding home health care sector—a space characterized by increasing demand due, in part, to an aging population.

Investors should take note of several key factors regarding this announcement and the broader context of Nova Leap Health. Firstly, the vesting schedule, which allows for 25% vesting immediately and the remainder on anniversaries of the grant date, indicates a long-term commitment to fostering leadership stability and driving sustained company performance. While the exercise price is set at CAD$0.35, a strategy aimed at retaining talent may also serve as a signal of intended value appreciation.

Additionally, Nova Leap holds a solid position within the home health care industry, particularly with its focus on dementia care, a critical service given the rise in neurological disorders. The company has received accolades for its growth trajectory, which bodes well for investor confidence.

Furthermore, its geographic diversification across key regions in the United States and Canada enhances its resilience against localized market fluctuations.

In conclusion, investors looking to tap into the growing home health care market may benefit from considering Nova Leap Health Corp. Its recent stock option grant not only aligns management incentives but also reinforces its commitment to growth and stability. However, potential investors should continue to monitor market conditions and Nova Leap’s operational performance to ensure alignment with their investment goals.